This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Mar 17;139(11):1609-1610.

doi: 10.1182/blood.2021013437.

POD24 in follicular lymphoma: time to be "wise"

John P Leonard¹

Affiliations

PMID: 35298602
DOI: 10.1182/blood.2021013437

Free article

Editorial

POD24 in follicular lymphoma: time to be "wise"

John P Leonard. Blood. 2022.

Free article

. 2022 Mar 17;139(11):1609-1610.

doi: 10.1182/blood.2021013437.

Author

John P Leonard¹

Affiliation

¹ Weill Cornell Medicine and New York Presbyterian Hospital.

PMID: 35298602
DOI: 10.1182/blood.2021013437

No abstract available

PubMed Disclaimer

Comment on

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster HS, Hiddemann W, Marcus R, Kimby E, Herold M, Sebban C, Gyan E, Foon K, Nielsen T, Vitolo U, Salles GA, Shi Q, Flowers CR. Casulo C, et al. Blood. 2022 Mar 17;139(11):1684-1693. doi: 10.1182/blood.2020010263. Blood. 2022. PMID: 34614146 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems